This platform - spun out of collaborative research between the University of Melbourne and DARPA (US) - acquires and decodes neural signals and uses them to control electromechanical devices, like prosthetic limbs. With applications that range from paralysis by stroke or spinal cord injury to MS or amputees, this start-up is set to enter clinical testing soon.
The University of Melbourne, through its affiliation with the Defence Science Institute, has provided funding to support early business development activities at SmartStent.
“When a promising technology platform is championed by enthusiastic, smart entrepreneurs, the possibilities are endless,” said Buzz Palmer, STC’s CEO. “SmartStent is on a path to success. That MedTech’s Got Talent was able to facilitate and accelerate that path is exactly what the program is all about.”
“This accelerator program has catapulted us from laboratory to board room,” said Thomas Oxley, SmartStent’s Managing Director. “We were mentored through a delicate beginning, exposed to influential figures in the local medtech industry, and are now pitching to international investors and multinational trade partners.”
MedTech’s Got Talent was supported by the Victorian Government through the Department of State Development, Business and Innovation. Further sponsors of the initiative were Cochlear, Griffith Hack, Second Nature, Leadership Management Australasia and BioMelbourne Network.